Jeffrey S. Parkin

Array ( [id] => 54411 [patent_doc_number] => 07767800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Nucleic acids obtained from LAVMAL, a variant African AIDS virus' [patent_app_type] => utility [patent_app_number] => 10/417217 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 12497 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767800.pdf [firstpage_image] =>[orig_patent_app_number] => 10417217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6634502 [patent_doc_number] => 20030211557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Rapid method of determining clearance of prion protein' [patent_app_type] => new [patent_app_number] => 10/406182 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4874 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211557.pdf [firstpage_image] =>[orig_patent_app_number] => 10406182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281228 [patent_doc_number] => 20040063605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Composition and method for the treatment or prevention of hiv infection' [patent_app_type] => new [patent_app_number] => 10/343174 [patent_app_country] => US [patent_app_date] => 2003-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3138 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063605.pdf [firstpage_image] =>[orig_patent_app_number] => 10343174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7462999 [patent_doc_number] => 20040053216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'DNA vaccines against hantavirus infections' [patent_app_type] => new [patent_app_number] => 10/394388 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 30541 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053216.pdf [firstpage_image] =>[orig_patent_app_number] => 10394388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136658 [patent_doc_number] => 20040044183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Peptide inhibitors of HIV entry' [patent_app_type] => new [patent_app_number] => 10/395817 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9440 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044183.pdf [firstpage_image] =>[orig_patent_app_number] => 10395817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219440 [patent_doc_number] => 20040072146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Mechanism of mitochondrial membrane permeabilization by HIV-1 Vpr, mimetics of Vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of Vpr with ANT' [patent_app_type] => new [patent_app_number] => 10/383592 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14938 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072146.pdf [firstpage_image] =>[orig_patent_app_number] => 10383592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6804666 [patent_doc_number] => 20030232060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Attenuated, doxycycline-inducible human immunodeficiency virus proviral molecular clones' [patent_app_type] => new [patent_app_number] => 10/376532 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7645 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232060.pdf [firstpage_image] =>[orig_patent_app_number] => 10376532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710015 [patent_doc_number] => 20060051360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Tat as an immunogen' [patent_app_type] => utility [patent_app_number] => 10/506408 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10111 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051360.pdf [firstpage_image] =>[orig_patent_app_number] => 10506408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369617 [patent_doc_number] => 07476390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Flavivirus antigens' [patent_app_type] => utility [patent_app_number] => 10/375932 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 20 [patent_no_of_words] => 126577 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476390.pdf [firstpage_image] =>[orig_patent_app_number] => 10375932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7317476 [patent_doc_number] => 20040224307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/367223 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 27449 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224307.pdf [firstpage_image] =>[orig_patent_app_number] => 10367223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840296 [patent_doc_number] => 07390624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Metal chelate-labelled peptides' [patent_app_type] => utility [patent_app_number] => 10/360647 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6154 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390624.pdf [firstpage_image] =>[orig_patent_app_number] => 10360647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 555242 [patent_doc_number] => 07470430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization' [patent_app_type] => utility [patent_app_number] => 10/359120 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 190 [patent_figures_cnt] => 211 [patent_no_of_words] => 60977 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470430.pdf [firstpage_image] =>[orig_patent_app_number] => 10359120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474018 [patent_doc_number] => 20040097420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Proteasome regulation of NF-kB activity' [patent_app_type] => new [patent_app_number] => 10/352512 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9382 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097420.pdf [firstpage_image] =>[orig_patent_app_number] => 10352512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730684 [patent_doc_number] => 20030186874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Hybrid polypeptides with enhanced pharmacokinetic properties' [patent_app_type] => new [patent_app_number] => 10/351641 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 26931 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186874.pdf [firstpage_image] =>[orig_patent_app_number] => 10351641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 209894 [patent_doc_number] => 07625566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Anti-idiotypic monoclonal antibody reactive with HIV neutralizing antibody 2F5' [patent_app_type] => utility [patent_app_number] => 10/501726 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7324 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/625/07625566.pdf [firstpage_image] =>[orig_patent_app_number] => 10501726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821298 [patent_doc_number] => 20030219459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Prion protein carrier-conjugates' [patent_app_type] => new [patent_app_number] => 10/346190 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 39449 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219459.pdf [firstpage_image] =>[orig_patent_app_number] => 10346190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769853 [patent_doc_number] => 20030215793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee' [patent_app_type] => new [patent_app_number] => 10/346000 [patent_app_country] => US [patent_app_date] => 2003-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14795 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215793.pdf [firstpage_image] =>[orig_patent_app_number] => 10346000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 209890 [patent_doc_number] => 07625565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Antiviral compositions comprising lysine-rich histone fractions prepared by pepsin treatment of thymic cell nuclei' [patent_app_type] => utility [patent_app_number] => 10/336512 [patent_app_country] => US [patent_app_date] => 2003-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 18281 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/625/07625565.pdf [firstpage_image] =>[orig_patent_app_number] => 10336512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711137 [patent_doc_number] => 20030170886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Method of developing an anti-protein and regulation of acellular function by administering and effective amount of the anti-protein' [patent_app_type] => new [patent_app_number] => 10/329764 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5024 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170886.pdf [firstpage_image] =>[orig_patent_app_number] => 10329764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4467967 [patent_doc_number] => 07943146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface' [patent_app_type] => utility [patent_app_number] => 10/327685 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 21874 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943146.pdf [firstpage_image] =>[orig_patent_app_number] => 10327685 [rel_patent_id] =>[rel_patent_doc_number] =>)